No Data
No Data
Bullish news! Margin trading and securities lending temporarily suspended!
A very heavy means of attacking short sellers.
Chen Yin has been recognized as a core technical personnel in Chengda Biotech (688739.SH)
Chengda Biotech (688739.SH) announced that Mr. Sun Shuxue, the company's core technical personnel, has applied for resignation due to personal reasons...
Chengda Biotechnology (688739.SH) will distribute 8 yuan per 10 shares in 2023. The record date for equity rights is June 19th.
Zhitoon Finance APP news, Chengda Biologicals (688739.SH) announced that the company will implement annual equity distribution in 2023, with a cash dividend of 8 yuan (including tax) for every 10 shares, with a stock registration date of June 19.
Chengda Biotech (688739.SH): Has repurchased a total of 1.6173 million shares of the company's own stock.
On June 3, Gelunhui reported that Chengda Biotechnology (688739.SH) announced that as of May 31, 2024, the company has repurchased a total of 1,617,267 shares of the company through the Shanghai Stock Exchange trading system through centralized bidding trading, accounting for 0.388% of the total share capital. The highest transaction price for the repurchase was 28.15 yuan/share, the lowest was 27.23 yuan/share, and the total amount of funds paid was 44,759,583.56 yuan.
Chengda Biotech (688739.SH): Has repurchased 0.388% of the company's shares
Gelonghui, May 6, 丨 Chengda Biotech (688739.SH) announced that as of April 30, 2024, the company had repurchased a total of 1,617,267 shares through the Shanghai Stock Exchange trading system, accounting for 0.388% of the company's total share capital. The highest price of the repurchase transaction was 28.15 yuan/share, the lowest price was 27.23 yuan/share, and the total amount of capital paid was RMB 44,759,583.56.
There May Be Some Bright Spots In Liaoning Chengda BiotechnologyLtd's (SHSE:688739) Earnings
Soft earnings didn't appear to concern Liaoning Chengda Biotechnology Co.,Ltd.'s (SHSE:688739) shareholders over the last week. We think that the softer headline numbers might be getting counterbalan
No Data